On April, 25. Investors wait Precision Drilling Corporation (TSE:PD) to reveal its quarterly earnings, RTT reports. Analysts predict 33.33 % diference or $-0.04 from the $-0.06 EPS from 2018. PD is reaching $3.17 during the last trading session, after increased 0.32%.Precision Drilling Corporation has volume of 757,768 shares. Since March 30, 2018 PD has 0.00% and is . PD underperformed by 4.37% the S&P500.

Precision Drilling Corporation (TSE:PD) Ratings Coverage

Total analysts of 5 have positions in Precision Drill (TSE:PD) as follows: 4 rated it a “Buy”, 1 with “Sell” and 0 with “Hold”. The positive are 80%. Since February 15, 2019 according to StockzIntelligence Inc Precision Drill has 6 analyst reports. On Tuesday, March 19 the stock has “Sell” rating by Scotia Capital. On Tuesday, March 19 the stock of Precision Drilling Corporation (TSE:PD) has “Buy” rating given by National Bank Canada. On Tuesday, March 19 the company was maintained by Raymond James. The company rating was maintained by BMO Capital Markets on Friday, February 15. The company rating was maintained by IBC on Tuesday, March 19.

Precision Drilling Corporation provides oil and natural gas drilling and related services and products.The firm is valued at $931.29 million. The firm operates in two divisions, Contract Drilling Services, and Completion and Production Services.Last it reported negative earnings. The Contract Drilling Services segment offers onshore well drilling services to exploration and production companies in the oil and natural gas industry.

For more Precision Drilling Corporation (TSE:PD) news published recently go to: Theglobeandmail.com, Warriortradingnews.com, Theglobeandmail.com, Warriortradingnews.com or Prnewswire.com. The titles are as follows: “Tuesday’s TSX breakouts: A marijuana stock that stands out from the pack – The Globe and Mail” published on August 21, 2018, “Canadian Cannabis Companies Worry About Future U.S. Competition – Warrior Trading News” on December 03, 2018, “The week’s most oversold and overbought stocks on the TSX – The Globe and Mail” with a publish date: December 07, 2018, “3 Marijuana Stocks That You Should Absolutely Avoid – Warrior Trading News” and the last “CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, MD, Ph.D., as the newly established SVP, Chief Translation Medicine Officer – PRNewswire” with publication date: December 10, 2018.